Search results
Order by most recent / most popular / relevance
Results: 1-10 of 114
Court grants motion to reopen trial and admit new evidence
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 27 2011
The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued
Pfizer Canada Inc. v. Novopharm, The Minister of Health, Northwestern University and the Board of Regents for the University of Oklahoma
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 5 2010
In a proceeding pursuant to the Patented Medicines (Notice of Compliance) Regulations, Novopharm brought a motion seeking a Protective Order that allowed the designation of Novopharm's Notice of Allegation (NOA) as confidential
Appeal of decision denying interlocutory injunction dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 4 2011
This was an appeal of a decision of the Federal Court, refusing an interlocutory motion
Supreme Court of Canada considers patent sufficiency requirements
- Borden Ladner Gervais LLP
- -
- Canada
- -
- November 8 2012
The Supreme Court issued its decision today in the much-anticipated patent case involving VIAGRA sildenafil
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Patent invalid for lack of sound prediction of utility - Eli Lilly v. Novopharm
- Borden Ladner Gervais LLP
- -
- Canada
- -
- November 21 2011
This decision is the second by the Trial Judge in this matter
Motion for leave to have more than five expert witnesses dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 5 2011
In a proceeding in which an impeachment action and an infringement action were consolidated, Apotex served eight expert reports
Court refuses to allow majority of pleadings to foreign jurisdictions
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 25 2011
The Court heard the dispute between the parties as to whether certain amendments to the amended Statement of Defence and Counterclaim should be allowed
Judicial review brought outside time period and no vested right to NOC
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This decision relates to the consideration by the Minister of Health of Apotex’ submission for a Notice of Compliance (NOC) for omeprazole magnesium
Definition of “innovative drug” does not include variations
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s
Current Search
- Workarea - Patents
- Workarea - Healthcare
- Firm Name - Borden Ladner Gervais LLP
- Jurisdiction - Canada
- Author - Chantal Saunders